A new method to synthesize creatine derivatives

Amino Acids

Volumn 45, Issue 4, 2013, Pages 821-833

  Garbati, Patrizia ^a   Salis, Annalisa ^a   Adriano, Enrico ^a   Galatini, Andrea ^a   Damonte, Gianluca ^a   Balestrino, Maurizio ^a   Millo, Enrico ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

Creatine; Creatine derivatives synthesis; Creatine reactivity; Guanidine group

Indexed keywords

AMIDE; AMINO ACID DERIVATIVE; BUTOXYCARBONYL DERIVATIVE; CARBONYL DERIVATIVE; CARBOXYLIC DERIVATIVE; CREATINE DERIVATIVE; CREATININE; GUANIDINE DERIVATIVE; ORGANIC SOLVENT; UNCLASSIFIED DRUG;

AMINO ACID SYNTHESIS; ANALYTIC METHOD; AQUEOUS SOLUTION; ARTICLE; CHEMICAL REACTION; CHEMOREACTIVITY; CONJUGATION; CYCLIZATION; DISSOLUTION; MOLECULAR STABILITY; PRIORITY JOURNAL;

CHEMISTRY TECHNIQUES, SYNTHETIC; CREATINE; MOLECULAR STRUCTURE;

EID: 84885309241     PISSN: 09394451     EISSN: 14382199     Source Type: Journal    
DOI: 10.1007/s00726-013-1525-x     Document Type: Article

References (38)

1. Adhihetty P, Beal M (2008) Creatine and its potential therapeutic value for targeting cellular energy impairment in neurodegenerative diseases. Neuromolecular Med 10(4):275-290. doi: 10.1007/s12017-008-8053-y
2. Adriano E, Garbati P, Damonte G, Salis A, Armirotti A, Balestrino M (2011) Searching for a therapy of creatine transporter deficiency: some effects of creatine ethyl ester in brain slices in vitro. Neuroscience 199:386-393. doi: 10.1016/j.neuroscience.2011.09.018
3. Andres RH, Ducray AD, Schlattner U, Wallimann T, Widmer HR (2008) Functions and effects of creatine in the central nervous system. Brain Res Bull 76:329-343. doi: 10.1016/j.brainresbull.2008.02.035
4. Balestrino M, Lensman M, Parodi M, Perasso L, Rebaudo R, Melani R, Polenov S, Cupello A (2002) Role of creatine and phosphocreatine in neuronal protection from anoxic and ischemic damage. Amino Acids 23(1-3):221-229. doi: 10.1007/s00726-001-0133-3
5. Beal M (2011) Neuroprotective effects of creatine. Amino Acids 1-9. doi: 10.1007/s00726-011-0851-0
6. Burov S, Leko M, Dorosh M, Dobrodumov A, Veselkina O (2011a) Creatinyl amino acids - new hybrid compounds with neuroprotective activity. J Pept Sci 17(9):620-626. doi: 10.1002/psc.1379
7. Burov S, Khromova NV, Khromova AA, Khromov PA (2011b) Patent US 2011/0269986 A1 Amides of creatine, method of their preparation, and remedy possessing a neuroprotective activity, Pub. Date Nov. 3, 2011
8. Carpino LA, Shroff H, Triolo SA, Mansour ESME, Wenschuh H, Albericio F (1993) The 2,2,4,6,7, pentamethyldihydrobenzofuran-5-sulfonyl group (Pbf) as arginine side chain protectant. Tetrahedron Lett 34(49):7829-7832. doi: 10.1016/S0040-4039(00)61487-9
9. Chaudhary A, Girgis M, Prashad M, Hu B, Har D, Repič O, Blacklock TJ (2003) Using mixed anhydrides from amino acids and isobutyl chloroformate in N-acylations: a case study on the elucidation of mechanism of urethane formation and starting amino acid liberation using carbon dioxide as the probe. Tetrahedron Lett 44(29):5543-5546. doi: 10.1016/S0040-4039(03)01329-7
10. Cheguillaume A, Salaün A, Sinbandhit S, Potel M, Gall P, Baudy-Floćh M, Le Grel P (2001) Solution synthesis and characterization of aza-beta(3)-peptides (N(alpha)-substituted hydrazino acetic acid oligomers). J Org Chem 66(14):4923-4929
11. Chen BC, Skoumbourdis AP, Guo P, Bednarz MS, Kocy OR, Sundeen JE, Vite GD (1999) A facile method for the transformation of N-(tert-butoxycarbonyl) α-amino acids to N-unprotected α-amino acids methyl esters. J Org Chem 64:9294-9296. doi: 10.1021/jo990311w
12. Dash AK, Sawhney A (2002) A simple LC method with UV detection for the analysis of creatine and creatinine and its application to several creatine formulations. J Pharm Biomed Anal 29(5):939-945. doi: 10.1016/S0731-7085(02) 00167-X
13. Edgar G, Shiver HE (1925) The equilibrium between creatine and creatinine in aqueous solution. The effect of the hydrogen ion. J Am Chem Soc 47(4):1179-1188
14. Greenhaff PL (2001) The creatine-phosphocreatine system: there's more than one song in its repertoire. J Physiol (Lond) 537(3):657. doi: 10.1113/jphysiol.2001.013478
15. Heuer MA, Maceougall J, Molins M (2009) Patent US 2009/0297685A1 Preparations containing creatine and imino sugars, Pub. Date Dec. 3, 2009
16. Isidro-Llobet A, Alvarez M, Albericio F (2009) Amino acid-protecting groups. Chem Rev 109:2455-2504. doi: 10.1021/cr800323s
17. Li J, Sha Y (2008) A convenient synthesis of amino acid methyl esters. Molecules 13(5):1111-1119. doi: 10.3390/molecules13051111
18. Lunardi G, Parodi A, Perasso L, Pohvozcheva AV, Scarrone S, Adriano E, Florio T, Gandolfo C, Cupello A, Burov SV, Balestrino M (2006) The creatine transporter mediates the uptake of creatine by brain tissue, but not the uptake of two creatine-derived compounds. Neuroscience 142(4):991-997. doi: 10.1016/j.neuroscience.2006.06.058
19. Nasrallah F, Feki M, Kaabachi N (2010) Creatine and Creatine Deficiency Syndromes: biochemical and clinical aspects. Pediatr Neurol 42(3):163-171. doi: 10.1016/j.pediatrneurol.2009.07.015
20. Negrisoli G, Del Corona L (1999) Hydrosoluble organic salts of creatine, Patent 5,973,199, Date of patent: Oct. 26, 1999
21. Nudelman A, Bechor Y, Falb E, Fischer B, Wexler BA, Nudelman A (1998) Acetyl chloride-methanol as a convenient reagent for: A) quantitative formation of amine hydrochlorides; B) carboxylate ester formation; C) mild removal of N-t-Boc-protective group. Synth Commun 28(3):471-474. doi: 10.1080/ 00397919808005101
22. Ohtsuki S, Tachikawa M, Takanaga T, Shimizu H, Watanabe TM, Hosoya K, Terasaki T (2002) The blood-brain barrier creatine transporter is a major pathway for supplying creatine to the brain. J Cereb Blood Flow Metab 22(11):1327-1335
23. Perasso L, Cupello A, Lunardi GL, Principato C, Gandolfo C, Balestrino M (2003) Kinetics of creatine in blood and brain after intraperitoneal injection in the rat. Brain Res 974(1-2):37-42. doi: 10.1016/S0006-8993(03)02547-2
24. Perasso L, Lunardi G, Risso F, Pohvozcheva A, Leko M, Gandolfo C, Florio T, Cupello A, Burov S, Balestrino M (2008) Protective effects of some creatine derivatives in brain tissue anoxia. Neurochem Res 33(5):765-775. doi: 10.1007/s11064-007-9492-9
25. Perasso L, Spallarossa P, Gandolfo C, Ruggeri P, Balestrino M (2013) Therapeutic use of creatine in brain or heart ischemia: available data and future perspectives. Med Res Rev 33(2):336-363. doi: 10.1002/med.20255
26. Peters J, MacDougall J, Chaudhuri S (2007) Creatine-fatty acid, Patent CA 2 577 439 A1, Pub. Date 07.05.2007
27. Pischel I, Gastner T (2008) Creatine - its chemical synthesis, chemistry, and legal status. In: Salomons GS, Wyss M (eds) Creatine and creatine kinase in health and disease subcellular biochemistry. Springer, Berlin, pp 291-307
28. Pischel I, Weiss S, Gloxhuber C, Mertschenk B (1999) Creatine ascorbates and method of producing them, Patent 5,863,939, Date of patent Jan. 26, 1999
29. Powell DA, Ramsden PD, Batey RA (2003) Phase-transfer-catalyzed alkylation of guanidines by alkyl halides under biphasic conditions: a convenient protocol for the synthesis of highly functionalized guanidines. J Org Chem 68(6):2300-2309. doi: 10.1021/jo0265535
30. Robinson S, Roskamp EJ (1997) Solid phase of guanidines. Tetrahedron 53(19):6697-6705. doi: 10.1016/S0040-4020(97)00225-1
31. Ruskin LS (1946) Sulphanilamide derivatives and method of preparing same, Patent US 2,407,686. Sept. 17, 1946
32. Schulze A (2003) Creatine deficiency syndromes. Mol Cell Biochem 244(1-2):143-150. doi: 10.1023/A:1022443503883
33. Singh S, Dash AK (2009) Creatine Monohydrate. In: Brittain HG (ed) Profiles of drug substances, excipients, and related methodology, vol 34, 1st edn. Elsevier, Oxford, pp 18-19
34. Smith-Palmer T (2002) Separation methods applicable to urinary creatine and creatinine. J Chromatogr B Analyt Technol Biomed Life Sci 781(1-2):93-106. doi: 10.1016/S1570-0232(02)00617-7
35. Snow RJ, Murphy RM (2001) Creatine and the creatine transporter: a review. Mol Cell Biochem 224(1-2):169-181. doi: 10.1023/A:1011908606819
36. Todoroki Y, Narita K, Muramatsu T, Shimomura H, Ohnishi T, Mizutani M, Ueno K, Hirai N (2011) Synthesis and biological activity of amino acid conjugates of abscisic acid. Bioorg Med Chem 19:1743-1750. doi: 10.1016/j.bmc.2011.01.019
37. Windholz M, Budavari S, Stroumtsos Y, Fertig MN (1976) The Merck index: an encyclopedia of chemicals, drugs, and biologicals, 9th edn. Merck, NJ
38. Zhu XF, Williams HJ, Scott AI (2000) Aqueous trifluoroacetic acid - an efficient reagent for exclusively cleaving the 5′-end of 3′,5′-TIPDS protected ribonucleosides. Tetrahedron Lett 41(49):9541-9545